Biology of Business

Door 1: GROW 1.5

Diversification Playbook

"I want to diversify / launch new things"

What you'll get

A diversification strategy with architecture design, DNA replication plan, stage-appropriate investment levels, and a 90-day execution sprint — producing launched initiatives with monitoring systems.

When to use this

When you want to launch multiple new products, enter adjacent markets, or build a portfolio of businesses. When the core business is strong and you have resources to diversify. When market concentration makes you vulnerable and you need to build portfolio resilience. When competitors are radiating into adjacent spaces and you need to respond.

The process

1

Radiation Potential Diagnosis

1 week
How to do this
Before committing to diversification, verify all three biological prerequisites for adaptive radiation. Ecological opportunity: are there underserved customer segments, emerging technologies, or regulatory changes creating new niches? Can you access these niches with existing capabilities? Is competition for these niches weak? Evolvability: does your organization have modular capabilities with API-like interfaces that can be recombined? Do you have standing variation in talent and ideas? Can you iterate rapidly? Isolation feasibility: can you create independent P&Ls and reporting lines? Can you prevent resource competition with core business? Can you tolerate divergent cultures and practices? Score each dimension and map to the decision matrix: if all three are strong, radiate. If evolvability is weak but others are strong, build modularity first (reform). If opportunity is weak, wait. If isolation is weak, focus on building structural separation. Also calibrate your stage-appropriate investment: seed stage companies should invest under 10% in niche construction, early stage 20-30%, growth stage 40-50%, and scale companies 30-40% in maintaining their niche.
What you'll need
  • Market opportunity analysis
  • Internal capability and modularity assessment
  • Organizational structure and decision-rights analysis
  • Company stage and financial metrics
  • Radiation potential score across three dimensions
  • Decision matrix placement: Radiate / Reform / Build / Wait / Focus
  • Stage-appropriate investment allocation guideline
  • Prerequisites gap list: what needs development before radiation
2

Platform Architecture Design

2-4 weeks (can begin in parallel with Step 1)
How to do this
Design the organizational architecture that enables diversification without chaos. The platform independence model establishes three principles. Shared infrastructure, independent products: identify core capabilities all products need (customer data, payments, compliance, authentication, analytics) and extract them into standalone services with stable API contracts. Each new venture consumes these services but does not depend on any other venture. Two-pizza teams: assign each niche or product to a dedicated small team (6-10 people) with full P&L responsibility. The team owns the product roadmap, hiring, and go-to-market within boundary rules. AWS pioneered this structure — each service team operates independently but shares infrastructure. Platform boundary rules: establish governance. Ventures can use platform services as-is or build alternatives. No single venture can veto changes that benefit the majority. Platform team maintains service quality but does not dictate product strategy. The key insight: diversification without platform architecture produces fragmented companies that duplicate effort and compete for shared resources. Diversification with platform architecture produces adaptive radiations where each species is specialized but the ecosystem is efficient.
What you'll need
  • Current organizational structure and capability inventory
  • Shared capabilities analysis
  • API and service boundary definitions
  • Platform architecture blueprint: shared services + independent venture teams
  • API contracts for shared capabilities
  • Two-pizza team charters with P&L boundaries
  • Platform governance document with boundary rules
3

DNA Identification and Replication Design

1-2 weeks
How to do this
Before replicating your success into new ventures, distinguish your organizational genotype (what generates success across contexts) from your phenotype (environment-specific adaptations). Run the Genotype Audit: for each element of your success, ask: does this work across different markets? Does this reflect a principle rather than a specific tactic? If this changed, would we fundamentally be a different organization? Can we codify this? Output: a 3-5 sentence organizational genotype document — the DNA that every new venture must carry. Then analyze the target environment for each new venture: what customer expectations, competitive adaptations, regulatory constraints, and cultural behaviors differ from your origin environment? Design phenotypic adaptations for each. Select the replication mode: asexual replication (franchising — proven model in stable environments), sexual replication (M&A — need capabilities you lack), horizontal transfer (best practice adoption from other companies), or epigenetic replication (cultural transmission through apprenticeship and immersion). Design fidelity mechanisms: training programs, certification, documentation, and mentorship that ensure DNA transfers correctly without mutation.
What you'll need
  • Organizational history and success patterns
  • Target environment analysis for each planned venture
  • Capability gap analysis
  • Organizational genotype document (3-5 sentences): the DNA every venture carries
  • Phenotype adaptation plan for each target environment
  • Selected replication mode with rationale
  • Fidelity mechanisms: training, certification, documentation, mentorship
4

Portfolio Vulnerability Audit

2 weeks
How to do this
Map your current portfolio as an ecosystem and identify where diversification adds genuine resilience versus mere complexity. Week 1: Map portfolio architecture. List all components (products, services, segments, geographies). Visualize as ecosystem. Document each component's function, resource requirements, environmental sensitivity, and correlation with others. Week 2: Calculate stability metrics. Concentration risk: what percentage comes from the top component and top three? Correlation structure: do components move together under stress? Response diversity: does a single event hurt most of the portfolio? Functional redundancy: how many components contribute to each critical function? Score each as RED, YELLOW, or GREEN. Then prioritize diversification opportunities by asking: does this new venture use different resources than existing ones? Does it respond differently to our nightmare scenarios? Does it share some capabilities (economies of scope)? Would it create resource competition or cannibalization? Classify each opportunity as STABILIZING (adds insurance), NEUTRAL (adds options), or DESTABILIZING (adds complexity without resilience).
What you'll need
  • Revenue breakdown by business unit, segment, geography
  • Historical performance during stress periods
  • Resource requirements per business unit
  • Portfolio Health Scorecard with RED/YELLOW/GREEN ratings
  • Top 3 portfolio vulnerabilities ranked
  • Each diversification opportunity classified as Stabilizing/Neutral/Destabilizing
  • Priority diversification targets that reduce genuine vulnerability
5

Radiation Tempo Selection and Launch

4-6 weeks
How to do this
Choose your radiation tempo and execute the launch sprint. Three tempo options. Sequential (AWS model): launch one venture, prove it, then launch the next. Lowest risk, slowest portfolio build. Best when capital is limited and each venture benefits from lessons learned by predecessors. Parallel (Alphabet model): launch multiple ventures simultaneously with independent teams. Highest resource requirement but fastest diversification. Best when you have abundant capital and the market window is closing. Hybrid (Unilever model): one primary venture with full resources plus 1-2 small experiments. Balances speed with learning. Best for most companies. Then execute the 90-day launch sprint. Weeks 1-2: Design diversification strategy — choose implementation pathway (acquire, build, or partner) for each opportunity. Weeks 3-6: Develop detailed execution plan with milestones, resources, metrics, contingencies. Secure budget approval and team assignments. Weeks 7-10: Launch primary initiative. Kickoff meeting, first customer conversations, MVP development. Weeks 11-13: Establish portfolio monitoring dashboards, quarterly review cadence, and plan the next 90-day sprint.
What you'll need
  • Portfolio vulnerability audit from Step 4
  • Platform architecture from Step 2
  • DNA replication plan from Step 3
  • Available resources and capital
  • Radiation tempo selected: Sequential / Parallel / Hybrid
  • Launch sequence with milestone gates between ventures
  • 90-day sprint execution plan with week-by-week actions
  • Portfolio monitoring dashboard and quarterly review cadence
  • Next 90-day sprint plan
6

Niche Construction and Defense

Ongoing — begins after launch
How to do this
Once ventures launch, shift from radiation to niche construction — actively shaping the competitive environment to favor your diversified position. Calibrate investment by stage. Pre-PMF ventures: under 10% on niche construction, 90%+ on product iteration. Adaptation dominates. Early ventures ($2-10M): 20-30% niche construction. Begin building defensive moats — proprietary data advantages, 2-3 pilot partnerships, customer switching costs. Growth ventures ($10-100M): 40-50% niche construction. Invest heavily in platform effects, regulatory positioning, vertical integration. At $50M, assess defensibility — if moats are thin, consider whether the venture has a path to structural defense or should be sold. Scale ventures ($100M+): 30-40% maintaining niche, 30-40% adjacent expansion, 20-30% core operations. Monitor for niche construction traps: when constructed niches become prisons that prevent necessary pivots. Track warning signs: your decisions visibly affect competitor strategies (power), customers use 3+ integrated products (lock-in), but market shifts require responses you cannot make (trap). The discipline is constructing niches that defend without imprisoning.
What you'll need
  • Venture stage and metrics
  • Competitive landscape per venture
  • Platform and integration metrics
  • Stage-appropriate niche construction investment allocation per venture
  • Specific niche construction tactics per venture (partnerships, data advantages, switching costs)
  • Niche trap monitoring metrics
  • Portfolio-wide niche health assessment
✓ Framework complete

Why this works — the biology

Hawaiian honeycreepers represent the most dramatic adaptive radiation on Earth. A single finch-like ancestor arrived on the Hawaiian Islands 5-7 million years ago and radiated into over 50 species with bill morphologies found nowhere else — from the short, thick bill of the Palila (seed-cracking specialist) to the dramatically curved bill of the Iiwi (nectar specialist) to the woodpecker-like bill of the Akiapolaau (bark-probing specialist). Three conditions made this possible. Ecological opportunity: the islands had empty niches because few mainland bird species had reached Hawaii. Evolvability: the ancestral finch's basic body plan was modular — bill shape, body size, and feeding behavior could vary independently without requiring the entire organism to redesign. Isolation: the islands were separated enough that populations on different islands could specialize without constant gene flow homogenizing them. AWS replicated this pattern: the ancestor (online bookstore infrastructure) arrived in an ecosystem with empty niches (cloud computing). The body plan was modular — compute, storage, networking, and databases could be offered as independent services. And structural separation (two-pizza teams with independent ownership) provided the isolation for each service to specialize. The DNA replication component draws from molecular biology: when cells divide, they do not copy every characteristic — they copy the genome (essential instructions) and let the new cell express those instructions differently based on its environment. Organizations that copy surface-level practices (phenotype) instead of underlying principles (genotype) produce replicas that fail in new environments.

See it in action: amazon

Amazon's diversification from online bookstore to the most diversified technology company in history follows the biological radiation pattern precisely. Radiation potential diagnosis: by 2002, Amazon had proven product-market fit in retail, had modular infrastructure (the systems that ran the bookstore could run any e-commerce), and Jeff Bezos had already implemented structural separation through two-pizza teams. All three prerequisites were met. Platform architecture: the 2002 Bezos API mandate (famously documented by Steve Yegge) required every team to expose functionality through service interfaces — creating the shared infrastructure that would become AWS. This was the platform independence model enacted as company policy: shared services, independent products, clear API boundaries. DNA replication: Amazon's organizational genotype is not 'selling books' or even 'e-commerce' but a set of principles: customer obsession, long-term thinking, willingness to be misunderstood for long periods, and operational excellence through systems rather than heroics. This genotype replicated across retail, AWS, Alexa, advertising, and logistics — each expressing the same DNA in radically different phenotypes. Portfolio vulnerability: Amazon's diversification systematically added response diversity. AWS revenue increases when enterprise IT budgets shift to cloud (counter-cyclical to retail). Advertising revenue grows with digital ad spending (independent of retail margins). Logistics capabilities turn a cost center into a revenue center. Each diversification made the portfolio more resilient, not just larger. Radiation tempo: sequential — books first, then general retail, then marketplace, then AWS, then devices, then advertising, then healthcare. Each venture proved before the next launched, with platform infrastructure compounding across all ventures.

Adapt to your context

single product to multi

Platform architecture design (Step 2) is the critical enabler. Without it, diversification creates internal competition for engineering resources, customer attention, and leadership bandwidth. Extract shared services before launching the second product.

conglomerate optimization

Portfolio vulnerability audit (Step 4) is primary. Most conglomerates have destabilizing diversity — correlated business units that respond identically to market stress. The biodiversity framework identifies where to reduce complexity and where to add genuine response diversity.

venture studio

DNA replication (Step 3) and radiation tempo (Step 5) are primary. Venture studios must codify what makes their ventures successful across contexts while allowing maximum phenotypic adaptation per venture. Parallel tempo is typical but sequential may produce higher-quality ventures.

geographic diversification

DNA replication is essential — geographic expansion requires distinguishing genotype (transferable principles) from phenotype (market-specific adaptations). The genotype audit prevents both over-standardization (forcing headquarters culture on local markets) and over-localization (losing organizational identity).

defensive diversification

Portfolio vulnerability audit drives the strategy. If concentration risk is the primary concern, prioritize ventures that add response diversity — components that perform well precisely when your core performs poorly.